Down-regulation of miR-126 is associated with colorectal cancer cells proliferation, migration and invasion by targeting IRS-1 via the AKT and ERK1/2 signaling pathways

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Zhou, Yu ^a,b   Feng, Xiao ^b   Liu, Ya Ling ^a   Ye, Shi Cai ^b   Wang, Hao ^b   Tan, Wen Kai ^b   Tian, Ting ^b   Qiu, Yu Mei ^b   Luo, He Sheng ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR SUBSTRATE; MICRORNA 126; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MICRORNA; MIRN126 MICRORNA, HUMAN; PROTEIN KINASE B;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL CYCLE ARREST; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; DOWN REGULATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; UPREGULATION; CELL CYCLE G0 PHASE; CELL MOTION; COLORECTAL TUMOR; ENZYME ACTIVATION; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION;

CARCINOGENESIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DOWN-REGULATION; ENZYME ACTIVATION; G0 PHASE; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; MAP KINASE SIGNALING SYSTEM; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84896691120     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081203     Document Type: Article

References (42)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108. (Pubitemid 40372904)
2. Walsh JM, Terdiman JP (2003) Colorectal cancer screening: scientific review. JAMA 289: 1288-1296. (Pubitemid 37432910)
3. Yang L, Parkin DM, Li L, Chen Y (2003) Time trends in cancer mortality in China: 1987-1999. Int J Cancer 106: 771-783. (Pubitemid 37006314)
4. Faltejskova P, Svoboda M, Srutova K, Mlcochova J, Besse A, et al. (2012) Identification and functional screening of microRNAs highly deregulated in colorectal cancer. J Cell Mol Med 16: 2655-2666.
5. Carthew RW (2006) Gene regulation by microRNAs. Curr Opin Genet Dev 16: 203-208.
6. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism and function. Cell 116: 281-297.
7. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838. (Pubitemid 40839735)
8. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866. (Pubitemid 44629897)
9. Kong W, Yang H, He L, Zhao JJ, Coppola D, et al. (2008) MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol 28: 6773-6784.
10. Park SM, Gaur AB, Lengyel E, Peter ME (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22: 894-907. (Pubitemid 351482843)
11. Zhang Y, Wang Z, Chen M, Peng L, Wang X, et al. (2012) MicroRNA-143 targets MACC1 to inhibit cell invasion and migration in colorectal cancer. Mol Cancer 11: 23.
12. Cai C, Ashktorab H, Pang X, Zhao Y, Sha W, et al. (2012) MicroRNA-211 Expression Promotes Colorectal Cancer Cell Growth In Vitro and In Vivo by Targeting Tumor Suppressor CHD5. PLoS One 7: e29750.
13. Yang J, Lan H, Huang X, Liu B, Tong Y (2012) MicroRNA-126 Inhibits Tumor Cell Growth and Its Expression Level Correlates with Poor Survival in Non-Small Cell Lung Cancer Patients. PLoS One 7: e42978.
14. Zhu N, Zhang D, Xie H, Zhou Z, Chen H, et al. (2011) Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2. Mol Cell Biochem 351: 157-164.
15. Li XM, Wang AM, Zhang J, Yi H (2011) Down-regulation of miR-126 expression in colorectal cancer and its clinical significance. Med Oncol 28: 1054-1057.
16. Guo C, Sah JF, Beard L, Willson JK, Markowitz SD, et al. (2008) The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer 47: 939-946.
17. Reiss K, Del Valle L, Lassak A, Trojanek J (2012) Nuclear IRS-1 and cancer. J Cell Physiol 227: 2992-3000.
18. Chang Q, Li Y, White MF, Fletcher JA, Xiao S (2002) Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications. Cancer Res 62: 6035-6038. (Pubitemid 35244449)
19. Slattery ML, Samowitz W, Curtin K, Ma KN, Hoffman M, et al. (2004) Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol Biomarkers Prev 13:1206-1214. (Pubitemid 38917910)
20. Shi B, Sepp-Lorenzino L, Prisco M, Linsley P, deAngelis T, et al. (2007) Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J Biol Chem 282: 32582-32590. (Pubitemid 350159311)
21. Yin Y, Yan ZP, Lu NN, Xu Q, He J, et al. (2013) Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1. Biochim Biophys Acta 1829: 239-247.
22. Kim EJ, Kang IJ, Cho HJ, Kim WK, Ha YL, et al. (2003) Conjugated linoleic acid downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells. J Nutr 133: 2675-2681. (Pubitemid 36935990)
23. Li N, Tang A, Huang S, Li Z, Li X, et al. (2013) MiR-126 suppresses colon cancer cell proliferation and invasion via inhibiting RhoA/ROCK signaling pathway. Mol Cell Biochem 380: 107-119.
24. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, et al. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601. (Pubitemid 351627379)
25. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, et al. (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136 (Pubitemid 351485639)
26. Zhang B, Pan X, Cobb GP, Anderson TA (2007) microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12. (Pubitemid 46096921)
27. Wang H, Wu J, Meng X, Ying X, Zuo Y, et al. (2011) MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. Carcinogenesis 32: 1033-1042.
28. Xu Q, Liu LZ, Qian X, Chen Q, Jiang Y, et al. (2012) MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res 40: 761-774.
29. Otsubo T, Akiyama Y, Hashimoto Y, Shimada S, Goto K, et al. (2011) MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis. PLoS One 6: e16617.
30. Zhang J, Du YY, Lin YF, Chen YT, Yang L, et al. (2008) The cell growth suppressor, mir-126, targets IRS-1. Biochem Biophys Res Commun 377: 136-140.
31. Crawford M, Brawner E, Batte K, Yu L, Hunter MG, et al. (2008) MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines.Biochem Biophys Res Commun 373: 607-612.
32. Miko E, Czimmerer Z, Csánky E, Boros G, Buslig J, et al. (2009) Differentially expressed microRNAs in small cell lung cancer. Exp Lung Res 35: 646-664.
33. Saito Y, Friedman JM, Chihara Y, Egger G, Chuang JC, et al. (2009) Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem Biophys Res Commun 379: 726-731.
34. Wang X, Tang S, Le SY, Lu R, Rader JS, et al. (2008) Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 3: e2557.
35. Bergmann U, Funatomi H, Kornmann M, Beger HG, Korc M (1996) Increased expression of insulin receptor substrate-1 in human pancreatic cancer. Biochem Biophys Res Commun 220: 886-890. (Pubitemid 26198607)
36. Dearth RK, Cui X, Kim HJ, Kuiatse I, Lawrence NA, et al. (2006) Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2. Mol Cell Biol 26: 9302-9314. (Pubitemid 44904425)
37. Sun H, Tu X, Baserga R (2006) A mechanism for cell size regulation by the insulin and insulin-like growth factor-I receptors. Cancer Res 66: 11106-11109. (Pubitemid 46009934)
38. Yamada N, Noguchi S, Mori T, Naoe T, Maruo K, et al. (2013) Tumor-suppressive microRNA-145 targets catenin δ-1 to regulate Wnt/ β-catenin signaling in human colon cancer cells. Cancer Lett 335: 332-342.
39. Strillacci A, Valerii MC, Sansone P, Caggiano C, Sgromo A, et al. (2013) Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells. J Pathol 229: 379-389.
40. Wang Z, Zhang X, Yang Z, Du H, Wu Z, et al. (2012) MiR-145 regulates PAK4 via the MAPK pathway and exhibits an antitumor effect in human colon cells. Biochem Biophys Res Commun 427: 444-449.
41. Sun D, Yu F, Ma Y, Zhao R, Chen X, et al. (2013) MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1). J Biol Chem 288: 9508-9518.
42. Iwaya T, Yokobori T, Nishida N, Kogo R, Sudo T, et al. (2012) Down-regulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway. Carcinogenesis 33: 2391-2397.